Cabergoline and pleural fibrosis Patient Reports February 12, 2012

Cabergoline Side Effects Report #4594003-4
Cabergoline side effect was reported by a Physician from on Feb 07, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis, restrictive pulmonary disease. Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, SIMVASTATIN, RAMIPRIL, ASPIRIN, MODURETIC. Patient recovered.

Cabergoline Side Effects Report #4642985-4
Cabergoline side effect was reported by a Physician from on Feb 17, 2005. Male patient, 74 years of age, weighting 180.8 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis, restrictive pulmonary disease. Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, SIMVASTATIN, RAMIPRIL, ASPIRIN, MODURETIC. Patient recovered.

Cabergoline Side Effects Report #5094396-8
Cabergoline side effect was reported by a Physician from DENMARK on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.

Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.


Cabergoline Side Effects Report #5606736-9
Cabergoline side effect was reported by a Health Professional from SWEDEN on Jan 21, 2008. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung infiltration, pleural fibrosis. Cabergoline dosage: unknown. During the same period patient was treated with HEMINEVRIN, ALVEDON, OXYCONTIN, CIPRAMIL, DUROFERON, ZAROXOLYN, FURIX, KALCITENA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4568054-X
Cabergoline side effect was reported by a Physician from on Jan 19, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung infiltration, pleural effusion, pleural fibrosis, right ventricular failure. Cabergoline dosage: 8 MG (8 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CLOMETHIAZOLE EDISILATE, ACETAMINOPHEN, OXYCODONE, CITALOPRAM HYDROBROMIDE, FERROUS SULPHATE, METOLAZONE, FUROSEMIDE, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4615374-6
Cabergoline side effect was reported by a Physician from on Mar 04, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG. Patient recovered.

Cabergoline Side Effects Report #4629445-1
Cabergoline side effect was reported by a Physician from on Mar 23, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, parkinson's disease , pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG (4 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4803614-X
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Sept 12, 2005. Female patient, 57 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis, pneumonitis. Cabergoline dosage: (8 MG, DAILY), ORAL. Patient recovered.


Cabergoline Side Effects Report #5605335-2
Cabergoline side effect was reported by a Physician from AUSTRALIA on Jan 17, 2008. Male patient, 48 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: crepitations, dyspnoea, hypoxia, pleural fibrosis. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, COMTAN. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #4741833-1
Cabergoline side effect was reported by a Physician from AUSTRALIA on July 27, 2005. Male patient, 48 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis. Cabergoline dosage: 8 MG (I MG, ONCE DAILY), ORAL. During the same period patient was treated with LEVODOPA, COMTAN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5150533-8
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 26, 2006. Female patient, 35 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pleural fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5685104-8
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Mar 18, 2008. Female patient, weighting 154.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , decreased appetite, dyspnoea exertional, pleural fibrosis, pneumonitis, weight decreased. Cabergoline dosage: unknown. During the same period patient was treated with COMTAN, LEXAPRO, DOMPERIDONE, SINEMET, SINEMET CR, TEMAZEPAM. Patient recovered.

Cabergoline Side Effects Report #4607416-9
Cabergoline side effect was reported by a Physician from on Nov 18, 2004. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis. Cabergoline dosage: unknown. Patient recovered.


Cabergoline Side Effects Report #4617799-1
Cabergoline side effect was reported by a Physician from on Mar 09, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural fibrosis, pulmonary fibrosis , scar . Cabergoline dosage: unknown. Patient recovered.